Ernst & Young / CE) & European Reference Networks / /
Continent
Europe / /
Event
FDA Phase / /
IndustryTerm
methodological tools / oil / /
MedicalCondition
Rare Diseases / /
Organization
MSs / Working Party / Member States on Improving Informed Decisions Based on the Clinical Added Value of Orphan Medicinal Products / European Union / European Commission / /
Recommendation of the EUCERD to the European Commission and Member States on Improving Informed Decisions Based on the Clinical Added Value of Orphan Medicinal Products (CAVOMP) Information Flow Adopted on 12 October 201